Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Andrew Young
AddedMar 31, 2024
UpdatedMay 31, 2026
Andrew Young

Andrew Young

Co-Founder, Satiogen Pharmaceuticals

CrunchbaseLinkedIn

Andrew Young's Career

Satiogen Pharmaceuticals
Satiogen Pharmaceuticals

San Diego, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Andrew Young's Career

Satiogen Pharmaceuticals
Satiogen Pharmaceuticals
Series A$700k52007San Diego, CA, US
Co-Founder

Leadership at Satiogen Pharmaceuticals

Slava GedulinSlava GedulinCo-Founder

Similar to Satiogen Pharmaceuticals

SatietySatietyPalo Alto, CA, USMedical Devicesest. 2000SatietyPalo Alto, CA, US · est. 2000

Satiety, Inc.: A US-based medical device company specializing in obesity treatment solutions.

Public · $71M30
GlyscendGlyscendBaltimore, MD, USDiabetes Treatmentest. 2014GlyscendBaltimore, MD, US · est. 2014

Glyscend: Pioneering revolutionary treatments for type 2 diabetes since 2014.

Series A · $22.4M16
Energesis PharmaceuticalsEnergesis PharmaceuticalsCambridge, MA, USDrugs, Pharmaceuticalsest. 2009Energesis PharmaceuticalsCambridge, MA, US · est. 2009

Energesis Pharmaceuticals: Innovating obesity and diabetes treatments by boosting body's energy expenditure.

Angel · $50k8
EndogenexEndogenexPlymouth, MN, USMedical Devicesest. 2017EndogenexPlymouth, MN, US · est. 2017

Endogenex: Innovating blood glucose management for Type 2 Diabetes through endoscopic procedures.

Series A · $25M25

Andrew Young's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Andrew Young

Allen A FienbergAllen A FienbergCo-Founder · Intra-Cellular TherapiesMichael BoiceMichael BoiceCo-Founder · RepairogenBrian CampbellBrian CampbellCo-Founder · MindImmune TherapeuticsRobert LippertRobert LippertCo-Founder · Atterx BioTherapeuticsPaul ThompsonPaul ThompsonFounder · CytoLogicAlex GasnerAlex GasnerCo-Founder · One Financial Holdings